Structural basis for activation and inhibition of class I phosphoinositide 3-kinases
Oscar Vadas1, John E Burke, Xuxiao Zhang
1Laboratory of Molecular Biology, Medical Research Council, Hills Road, Cambridge CB20QH, UK. ovadas@mrc-lmb.cam.ac.uk
Abstract:
Phosphoinositide 3-kinases (PI3Ks) are implicated in a broad spectrum of cellular activities, such as growth, proliferation, differentiation, migration, and metabolism. Activation of class I PI3Ks by mutation or overexpression correlates with the development and maintenance of various human cancers. These PI3Ks are heterodimers, and the activity of the catalytic subunits is tightly controlled by the associated regulatory subunits. Although the same p85 regulatory subunits associate with all class IA PI3Ks, the functional outcome depends on the isotype of the catalytic subunit. New PI3K partners that affect the signaling by the PI3K heterodimers have been uncovered, including phosphate and tensin homolog (PTEN), cyclic adenosine monophosphate-dependent protein kinase (PKA), and nonstructural protein 1. Interactions with PI3K regulators modulate the intrinsic membrane affinity and either the rate of phosphoryl transfer or product release. Crystal structures for the class I and class III PI3Ks in complexes with associated regulators and inhibitors have contributed to developing isoform-specific inhibitors and have shed light on the numerous regulatory mechanisms controlling PI3K activation and inhibition.
Insights
Phosphoinositide 3-kinases (PI3Ks) regulate cell growth and metabolism. Understanding PI3K regulation and interactions is crucial for developing targeted cancer therapies.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Phosphoinositide 3-kinases (PI3Ks) are critical enzymes involved in numerous cellular processes, including growth, proliferation, and metabolism.
- Aberrant PI3K activity, particularly class I PI3Ks, is frequently observed in human cancers, driving their development and progression.
Purpose of the Study:
- To elucidate the regulatory mechanisms controlling PI3K activity.
- To explore the role of PI3K partners in modulating signaling pathways.
- To inform the development of isoform-specific PI3K inhibitors for cancer therapy.
Main Methods:
- Review of existing literature on PI3K structure, function, and regulation.
- Analysis of protein-protein interactions involving PI3K and its regulators.
- Examination of structural data for PI3K complexes.
Main Results:
- PI3Ks are heterodimers where catalytic subunit activity is controlled by regulatory subunits (e.g., p85).
- Functional outcomes are influenced by the specific catalytic subunit isotype.
- Novel PI3K partners (PTEN, PKA, nonstructural protein 1) modulate PI3K signaling.
- Interactions with regulators affect membrane affinity and catalytic rates.
- Crystal structures reveal regulatory mechanisms and aid inhibitor design.
Conclusions:
- PI3K regulation is complex, involving subunit interactions and numerous partners.
- Understanding these interactions is key to targeting PI3K in cancer.
- Structural insights facilitate the development of specific inhibitors for therapeutic intervention.
More Related Videos
Related Concept Videos
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
The JAK-STAT Signaling Pathway
IP3/DAG Signaling Pathway
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Amplifying Signals via Enzymatic Cascade


